Case Study

CAR T Study For Blockbuster Drug Granted Breakthrough Therapy Designation For Multiple Myeloma

GettyImages-1384297905 car t study

A pharmaceutical sponsor needed help with a two-part, multisite Phase 1 study in adults with relapsed/refractory multiple myeloma. Specifically, the sponsor was looking for a team with CAR T experience, and a system that could handle their unique database built. In addition, the sponsor also required a team that could provide in-house data management, as well as a biostatistical team.

Discover how the company was able to overcome prior vendor relationship frustrations and receive support for a database build of EDC and IRT, as well as get aid with data management and biostatistics.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader